Ausgabe 10/2007
Inhalt (11 Artikel)
Signalling pathways involved in clinical responses to chemotherapy
R. Perona, I. Sánchez-Pérez
Pharmacodynamics: biological activity of targeted therapies in clinical trials
F. Rojo, A. Dalmases, J. M. Corominas, J. Albanell
Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals
F. C. Muñoz-Casares, S. Rufián, M. J. Rubio, E. Lizárraga, C. Díaz-Iglesias, E. Aranda, R. Ciria, J. Muntané, P. Barrios, J. Torres-Melero, S. González-Moreno, L. González-Bayón, B. Camps, P. Bretcha, J. Farré, G. Ortega-Pérez, A. Gómez-Portilla
Can the clinical outcome in state II colon carcinomas be predicted by determination of molecular marker expression?
J. M. Fernández-Cebrián, M. Nevado Santos, P. Vorwald Kuborn, M. Pardo de Lama, J. Martín-Cavanna, P. Pacheco Martínez, B. Fernández Escudero, M. Ramos Fernández
Sorafenib TARGET Trial results in Spanish patients
J. Bellmunt, J. L. González-Larriba, M. Á. Climent, G. López-Vivanco, L. Urruticoechea, J. Albanell
Glucagonoma with two pancreatic masses and pulmonary metastases as debut of MEN-1
V. Gutiérrez, M. Cobo, D. Olea, J. García, C. Ramírez, D. Bautista, J. Alcalde
Intrahepatic mucinous biliary cystadenoma
A. Díaz de Liaño, E. Olivera, C. Artieda, C. Yárnoz, H. Ortiz